Trial
NCT01329744
Effects of IGF-I in HIV Metabolic Disease
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
HIV Lipodystrophy
Intervention
mecasermin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-23